long-term follow-up of a "fast-dc" immunotherapy as a post-remission strategy for aml
Published 3 years ago • 200 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
8:33
boven regimen for previously untreated cll: long-term follow-up and mrd kinetics
-
2:26
improving long-term outcomes with intensive chemotherapy in aml: looking to the future
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
13:42
w hematologii jesteśmy w przełomowym momencie
-
29:16
szpiczak plazmocytowy – nowości: iii i kolejne linie leczenia
-
1:08:29
chapter 1: electrostatic
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
2:17
extended follow-up of the master trial
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
14:43
current research into post-allosct maintenance therapy in aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
2:09
advances in the management of fit adults with aml
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:55
long-term real-world experience of cpx-351 in patients with t-aml and mrc-aml
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸